Your browser doesn't support javascript.
loading
KRAS and EGFR Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in EGFR.
Nakatani, Kaori; Yamaoka, Toshimitsu; Ohba, Motoi; Fujita, Ken-Ichi; Arata, Satoru; Kusumoto, Sojiro; Taki-Takemoto, Iori; Kamei, Daisuke; Iwai, Shinichi; Tsurutani, Junji; Ohmori, Tohru.
Afiliación
  • Nakatani K; Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Tokyo, Japan.
  • Yamaoka T; Advanced Cancer Translational Research Institute (formerly, Institute of Molecular Oncology), Tokyo, Japan. yamaoka.t@med.showa-u.ac.jp.
  • Ohba M; Advanced Cancer Translational Research Institute (formerly, Institute of Molecular Oncology), Tokyo, Japan.
  • Fujita KI; Advanced Cancer Translational Research Institute (formerly, Institute of Molecular Oncology), Tokyo, Japan.
  • Arata S; Advanced Cancer Translational Research Institute (formerly, Institute of Molecular Oncology), Tokyo, Japan.
  • Kusumoto S; Center for Biotechnology, Showa University, Tokyo, Japan.
  • Taki-Takemoto I; Division of Allergology and Respiratory Medicine, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Kamei D; Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Tokyo, Japan.
  • Iwai S; Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Tokyo, Japan.
  • Tsurutani J; Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Tokyo, Japan.
  • Ohmori T; Advanced Cancer Translational Research Institute (formerly, Institute of Molecular Oncology), Tokyo, Japan.
Mol Cancer Ther ; 18(1): 112-126, 2019 01.
Article en En | MEDLINE | ID: mdl-30322949
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos